Less Frequent Cisplatin Superior in Head, Neck Cancer ...Middle East

News by : (Medscape) -
A higher dose of cisplatin given once every 3 weeks provided better locoregional control than a lower weekly dose in patients with locally advanced head and neck cancer. Medscape Medical News

Hence then, the article about less frequent cisplatin superior in head neck cancer was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Less Frequent Cisplatin Superior in Head, Neck Cancer )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار